DEEPAK JAIN: Open Payments
NPI 1356368823 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 73 payments from 21 companies in 2025. Trend: 2023 $1,353 · 2024 $1,755 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $587 |
| Kestra Medical Technology Services, Inc. | 1 | $178 |
| Eisai Inc. | 5 | $93 |
| Exact Sciences Corporation | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| Lilly USA, LLC | 5 | $82 |
| ABIOMED | 1 | $80 |
| Amgen Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $55 |
| Novo Nordisk Inc | 3 | $50 |
Products named: TEZSPIRE, BREZTRI, Assure WCD, FARXIGA, Leqembi, Kerendia, JARDIANCE, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
